Valuation: Evotec SE

Market Cap 60Cr 70Cr 56Cr 51Cr 96Cr 6.66TCr 97Cr 660.35Cr 256.77Cr 3.35TCr 261.35Cr 255.69Cr 11TCr P/E 2026 *
-2.86x
P/E 2027 * -7.8x
Enterprise Value 74Cr 86Cr 69Cr 63Cr 119.33Cr 8.26TCr 120.6Cr 818.48Cr 318.26Cr 4.15TCr 323.94Cr 316.92Cr 14TCr EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.05x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-1.08%
1 week-2.53%
Current month-3.44%
1 month-3.55%
3 months-34.71%
6 months-42.33%
Current year-39.38%
1 week 3.25
Extreme 3.254
3.47
1 month 3.25
Extreme 3.254
3.82
Current year 3.24
Extreme 3.238
6.66
1 year 3.24
Extreme 3.238
7.49
3 years 3.24
Extreme 3.238
23.25
5 years 3.24
Extreme 3.238
45.7
10 years 3.24
Extreme 3.238
45.7
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%-2.53% - - 70Cr
-0.74%+3.78%+2.62%+23.10% 5.16TCr
+0.67%-0.96%+488.62%+559.84% 4.49TCr
-0.33%+7.33%+37.71%+20.15% 4.28TCr
-0.72%+2.78%+20.73%+87.35% 4.26TCr
+0.88%-3.48%+17.20%+57.20% 3.18TCr
-0.94%+3.14%+31.93%+143.59% 1.73TCr
-0.86%+1.67% - - 1.66TCr
+0.58%+4.66%+9.77%+30.87% 1.48TCr
-0.67%+2.29%+78.66%+47.62% 1.41TCr
Average -0.36%+4.83%+85.91%+121.21% 3.07TCr
Weighted average by Cap. -0.28%+5.13%+103.60%+139.86%

Financials

2026 *2027 *
Net sales 60Cr 70Cr 56Cr 51Cr 97Cr 6.7TCr 98Cr 663.83Cr 258.13Cr 3.36TCr 262.73Cr 257.04Cr 11TCr 72Cr 84Cr 67Cr 62Cr 116.08Cr 8.04TCr 117.31Cr 796.14Cr 309.57Cr 4.03TCr 315.09Cr 308.27Cr 13TCr
Net income -24Cr -28Cr -22Cr -20Cr -38Cr -2.64TCr -38Cr -261.07Cr -101.52Cr -1.32TCr -103.33Cr -101.09Cr -4.38TCr -6.04Cr -7.04Cr -5.65Cr -5.16Cr -9.74Cr -674.53Cr -9.85Cr -67Cr -26Cr -338.71Cr -26Cr -26Cr -1.12TCr
Net Debt 14Cr 17Cr 13Cr 12Cr 23Cr 1.6TCr 23Cr 158.13Cr 61Cr 801.45Cr 63Cr 61Cr 2.65TCr 16Cr 19Cr 15Cr 14Cr 26Cr 1.81TCr 26Cr 179.52Cr 70Cr 909.82Cr 71Cr 70Cr 3.01TCr
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
24/26/24 3.310 -0.48% 1,000
21/26/21 €3.326 -2.18% 0
20/26/20 €3.400 -1.39% 8,451
19/26/19 €3.448 +1.23% 5,710
18/26/18 €3.406 +0.29% 5,250
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.356EUR
Average target price
4.586EUR
Spread / Average Target
+36.64%

Quarterly revenue - Rate of surprise